← All launches
0 Report

GLPcompare: US GLP-1 cash prices

by FastDrop

MCP Verified 1 hour ago Registry import free

US GLP-1 cash prices by seller, ranked per 30 days, with check dates and source pages.

US GLP-1 cash prices by seller, ranked per 30 days, with check dates and source pages. Official MCP Registry: co.glpcompare/glp1-prices@1.0.0. Remote endpoint: https://glpcompare.co/api/mcp

Problem it solves

Discoverable MCP server listed in the official MCP Registry.

How it's different

Remote MCP endpoint ingested from the official registry and probed by FastDrop.

Ingested from the official MCP Registry

FastDrop pulled this entry from the official MCP Registry as co.glpcompare/glp1-prices and probed the endpoint. The maker did not submit it, so the outbound link is not endorsed and the description is not theirs.

If this is your server, claim the listing to edit it and take ownership. The registry index lists everything else still awaiting a probe.

Claim this listing

Tools this endpoint exposes

Read directly from the endpoint on 6 Nov 2026. Not supplied by the maker.

  • find_glp1_prices

    Lowest current US self-pay prices of a GLP-1 medication, ranked by cost per 30 days. Accepts a brand (Zepbound, Wegovy), an ingredient (semaglutide returns its brands and the compounded list), or a co

  • find_seller_glp1_prices

    Current US self-pay GLP-1 prices of one seller, such as Ro, Hims & Hers, LillyDirect or Wellmedr, ranked by cost per 30 days. Only prices that state the supply they buy are ranked. Returns each produc

  • list_glp1_medications

    Every GLP-1 medication GLPcompare keeps a price list for, with how many ranked prices each has and its page.

Is this tool yours?

Claim this listing, then prove you own the domain with one DNS record: once it matches, the listing is yours right away.

Sign in to claim this listing

Matched on shared tags and the tools their MCP servers actually expose.

Reviews

Sign in to leave a review.

No reviews yet.

Comments

Sign in to join the discussion.

No comments yet - start the discussion.